Supporting Meal Management in Type 1 Diabetes
SUMMIT1
1 other identifier
interventional
44
1 country
1
Brief Summary
Carbohydrate count marks the cornerstone of Type 1 Diabetes management. Eventhough it is a crucial task, it is burdensome and prone to error. Therefore, the investigators want to explore the effect that SNAQ, a food analyser app would have in glycaemic control by facilitating the task of carbohydrate estimation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2022
CompletedFirst Posted
Study publicly available on registry
January 5, 2023
CompletedStudy Start
First participant enrolled
March 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 8, 2024
CompletedNovember 13, 2024
June 1, 2024
1.1 years
December 22, 2022
November 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of time with sensor glucose in the target range
Percentage of time with sensor glucose in the target range between 3.9 to 10.0mmol/L, %
3-week intervention period (Day 1 to Day 21)
Secondary Outcomes (5)
Percentage of time with sensor glucose in hyperglycaemia
3-week intervention period (Day 1 to Day 21)
Percentage of time with sensor glucose in hypoglycaemia
3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in target range
3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in hyperglycaemia
3-week intervention period (Day 1 to Day 21)
Percentage of postprandial time with sensor glucose in hypoglycaemia
3-week intervention period (Day 1 to Day 21)
Study Arms (2)
Intervention
EXPERIMENTALThe intervention group will use SNAQ app for the first 3 weeks (baseline to V1) of the study.
Control
ACTIVE COMPARATORThe control group will continue estimating the carbohydrate count using their traditional methods for the first three weeks of the study (baseline to V1).
Interventions
SNAQ is a smartphone food analysis app that estimates the macronutrient content of a meal, based on a single image. The app first determines meal content in terms of food components with input from the user to correct or add further components (e.g. foods, ingredients, sauces, herbs or seasonings). Then, the total macronutrient and energy content of the meal is determined based on the estimated volume and information from a nutritional database. Of note, the application also allows for assessing nutritional content of packaged foods by means of a barcode scanning function. The user can always adapt proposed nutritional contents at their own discretion. Meal macronutrients alongside the food pictures are collected in a detailed log which allows users to review their dietary choices. The product is not conceived by its manufacturer to be used for medical purposes and can thus not be considered a medical device.
Patients will follow their traditional methods of carbohydrate counting during the control period. In addition to assess sustainability of the intervention, following the control period, the control group will also go an intervention period of 3 weeks using the SNAQ App.
Eligibility Criteria
You may qualify if:
- Written informed consent
- Adults (aged 18 years or older)
- Type 1 diabetes (as defined by World Health Organization (WHO) for at least 12 month)
- Current use of a commercial hybrid closed-loop system
- HbA1c≤12% (measured within the past 3 months)
- Willing to use the SNAQ app on a daily basis for over 3 weeks
- The participant is willing to follow study specific instructions and share their treatment data with the study team
You may not qualify if:
- Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results
- Previous use of SNAQ app for more than 5 days within the past 3 months
- Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding
- Severe visual impairment
- Severe hearing impairment
- Lack of reliable telephone facility for contact
- Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results
- Participant not proficient in German
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lia Ballylead
Study Sites (1)
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital
Bern, Canton of Bern, 3010, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lia Bally, MD PhD
UDEM Inselspital, University Hospital of Berne, and University Berne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Research and Head of Nutrition, Metabolism and Obesity
Study Record Dates
First Submitted
December 22, 2022
First Posted
January 5, 2023
Study Start
March 27, 2023
Primary Completion
May 8, 2024
Study Completion
May 8, 2024
Last Updated
November 13, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After publication of the study results in a peer-reviewed journal.
- Access Criteria
- Contact with an approval by the corresponding author.
Anonymised individual participant data will be shared after inquiry via a validated sharing platform (yet to be defined). Anonymised data packages will be available once the final study results are published in a peer-reviewed journal.